Bio-Rad Laboratories | BIO - 债务





债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Agilent USD 3.35B 0 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Charles River Laboratories USD 2.57B 58.23M 2025-12
Danaher USD 26.56B 8.07B 2026-06
General Electric Aerospace USD 19.16B 1.12B 2026-06
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
Laboratory Of America USD 7.24B 714.6M 2026-03
Merck USD 49.34B 7.97B 2025-12
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quest Diagnostics USD 6.41B 179M 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Roche Holding CHF 33.03B 1.41B 2025-06
Siemens EUR 56.46B 450M 2025-12
Standard Biotools USD 29.49M 2.1M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Tosoh JPY 172.31B 6.79B 2025-09
Waters USD 1.49B 4.92M 2025-12